The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Survival rates for many cancers have improved due to new treatments and earlier detection. Yet cases of some cancers, such as ...

Cancer survival rates have reached a record high, according to a new report from the American Cancer Society (ACS). The ...

Japan’s health ministry has released, for the first time, five-year survival rates for new cancer patients by cancer type, ...

Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, ...

GT Biopharma targets a portion of the estimated $362 billion global solid tumor marketPreliminary, unaudited cash balance of approximately $7 ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

The American Cancer Society's 75th annual cancer statistics report reveals significant progress in cancer treatment and ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...